Maintenance Dose Calculator

Enter drug clearance, target steady-state concentration, dosing interval, and bioavailability to calculate the required maintenance dose and daily dosing regimen.

Created by Luis GonzalezLast updated: May 9, 2026

How to Use This Calculator

1
Enter Drug Clearance (L/hr)
Input the rate at which the drug is removed from the body, typically in litres per hour. This is a crucial pharmacokinetic parameter.
2
Specify Target Steady-State Concentration (mg/L)
Provide the desired average plasma drug concentration once the drug's intake and elimination are balanced (Css). This ensures therapeutic efficacy.
3
Input Dosing Interval (hr)
Enter the time between consecutive doses in hours. For example, enter '12' for a twice-daily dosing regimen.
4
Provide Bioavailability (F)
Input the fraction of the administered dose that reaches systemic circulation, expressed as a value between 0 and 1. Use '1' for intravenous (IV) dosing.
5
Review Your Maintenance Dose Calculations
The calculator will display the maintenance dose per interval, total daily dose, doses per day, and other pharmacokinetic insights.

Example Calculation

A pharmacist needs to calculate the maintenance dose for a drug with a clearance of 5 L/hr, a target steady-state concentration of 10 mg/L, a dosing interval of 12 hours, and 100% bioavailability (F=1).

Drug Clearance (L/hr)

Target Steady-State Concentration (mg/L)

Dosing Interval (hr)

Bioavailability (F)

Results

600 mg

Tips

Account for Renal Impairment

For renally cleared drugs, always adjust the clearance value for patients with impaired kidney function. A common approach is to use a creatinine clearance (CrCl) estimate to scale the drug's typical clearance, ensuring safe and effective dosing.

Therapeutic Drug Monitoring

For drugs with a narrow therapeutic index, such as digoxin or phenytoin, target steady-state concentrations should be verified through therapeutic drug monitoring (TDM) by measuring plasma levels to prevent toxicity or sub-therapeutic dosing.

Bioavailability for Oral Dosing

Oral bioavailability (F) is rarely 1 (100%) due to incomplete absorption or first-pass metabolism. Always use the specific bioavailability fraction for oral formulations, often ranging from 0.2 to 0.9, to accurately convert from IV to oral doses.

Calculating Sustained Drug Levels for Optimal Therapy

The Maintenance Dose Calculator is a critical tool for pharmacists, physicians, and healthcare professionals to determine the appropriate amount of medication required to maintain a consistent therapeutic concentration in a patient's bloodstream over time. By incorporating key pharmacokinetic parameters—drug clearance, target steady-state concentration, dosing interval, and bioavailability—this calculator ensures that drug regimens are both effective and safe. Precise calculation helps avoid sub-therapeutic levels or toxicity, a fundamental aspect of patient care in 2025.

The Importance of Steady-State in Drug Therapy

Achieving and maintaining a steady-state concentration (Css) is paramount in drug therapy. It ensures that the drug's therapeutic effects are consistent, without the peaks and troughs that can lead to adverse effects or treatment failure. For many chronic conditions, medications are designed to be taken regularly to keep the drug's concentration within a specific therapeutic window. The maintenance dose calculation directly addresses this need by balancing the rate of drug administration with the body's rate of drug elimination, thereby stabilizing plasma levels.

The Pharmacokinetic Formula for Maintenance Dosing

The maintenance dose ($D_M$) is calculated using a fundamental pharmacokinetic principle that relates the drug's clearance (Cl), the desired target steady-state concentration (Css), the dosing interval (τ), and the drug's bioavailability (F). This formula ensures that the amount of drug administered per dosing interval is sufficient to replace the amount eliminated from the body, leading to stable therapeutic levels.

Maintenance Dose (DM) = (Clearance (Cl) × Target Steady-State Concentration (Css) × Dosing Interval (τ)) / Bioavailability (F)

Here, Cl is typically in L/hr, Css in mg/L, τ in hours, and F is a unitless fraction (0 to 1). The result, DM, will be in mg.

💡 To understand the systemic absorption of a drug, especially for oral medications, our Bioavailability Calculator can help quantify how much of a dose reaches its target.

Determining a Drug's Maintenance Dose

Imagine a clinical scenario where a new oral medication is being prescribed. The drug has a known clearance rate of 5 L/hr, the desired target steady-state concentration (Css) for therapeutic effect is 10 mg/L, the patient will be dosed every 12 hours (dosing interval τ = 12 hr), and the oral formulation has a bioavailability (F) of 1 (indicating complete absorption, similar to IV for calculation simplicity).

Identify Parameters:
- Clearance (Cl) = 5 L/hr
- Target Steady-State Concentration (Css) = 10 mg/L
- Dosing Interval (τ) = 12 hr
- Bioavailability (F) = 1
Apply the Formula:
- Maintenance Dose = (5 L/hr × 10 mg/L × 12 hr) / 1
- Maintenance Dose = 600 mg

Therefore, a maintenance dose of 600 mg every 12 hours would be required to achieve and sustain the target steady-state concentration for this drug. This calculation is vital for establishing effective patient treatment plans.

💡 After dosing, monitoring drug exposure is critical. Our AUC (Area Under the Curve) Calculator helps quantify total drug exposure over time, a key metric in pharmacokinetics.

Factors Influencing Drug Dosing

Drug dosing is a complex process influenced by numerous physiological and pathological factors. Patient-specific variables like age, weight, gender, and genetic makeup can significantly alter drug metabolism and excretion. For instance, elderly patients often have reduced renal and hepatic function, necessitating lower doses or extended dosing intervals. Furthermore, comorbidities such as kidney disease or liver impairment can drastically reduce drug clearance, leading to accumulation if doses are not adjusted. Drug-drug interactions, where one medication affects the metabolism or transport of another, also require careful consideration. Clinicians must integrate these factors with pharmacokinetic principles to personalize therapy, ensuring both efficacy and patient safety.

Regulatory Considerations for Drug Dosing

Drug dosing is heavily regulated by authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to ensure safety and efficacy. These bodies require extensive clinical trials to establish appropriate dose ranges, dosing intervals, and special population considerations (e.g., pediatric, geriatric, renally impaired patients) before a drug can be marketed. Furthermore, guidelines from organizations like the American Society of Health-System Pharmacists (ASHP) and various medical societies often provide practical recommendations for dose adjustments in specific clinical scenarios, such as for patients with varying creatinine clearance levels. Non-compliance with established dosing protocols can lead to serious patient harm and regulatory penalties, underscoring the critical importance of accurate and informed drug administration.

Frequently Asked Questions

What is a maintenance dose in pharmacology?

A maintenance dose is the amount of drug administered regularly to keep the plasma drug concentration within the therapeutic range over an extended period. The goal is to achieve and sustain a steady-state concentration where the rate of drug administration equals the rate of drug elimination, ensuring consistent therapeutic effects without accumulation or sub-therapeutic levels.

Why is drug clearance important for maintenance dosing?

Drug clearance is a critical pharmacokinetic parameter representing the volume of plasma cleared of the drug per unit of time. A higher clearance rate means the drug is eliminated faster, requiring a larger or more frequent maintenance dose to sustain therapeutic concentrations, especially in patients with normal organ function.

What is steady-state concentration and why is it targeted?

Steady-state concentration (Css) is the point at which the amount of drug entering the body equals the amount being eliminated, resulting in stable plasma drug levels. Targeting Css ensures that the drug exerts its desired therapeutic effect consistently, minimizing fluctuations that could lead to toxicity (if too high) or lack of efficacy (if too low).

How does bioavailability affect maintenance dose calculations?

Bioavailability (F) is the fraction of an administered drug dose that reaches systemic circulation in an unchanged form. For non-intravenous routes, bioavailability is less than 1, meaning a larger dose is required to achieve the same systemic exposure as an IV dose. The maintenance dose formula explicitly divides by F to compensate for incomplete absorption.